MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2016 International Congress

    The condition of cerebral hemodynamics in the secondary vascular parkinsonism

    D. Akramova, A. Umarov, G. Rakhimbaeva, M. Ataniyazov, D. Shosaidova (Tashkent, Uzbekistan)

    Objective: To study influence of narrowing lesion of the main brain arteries to progress of secondary vascular stenosis prognosticate stenosis degree and prevent risk factors…
  • 2016 International Congress

    Serum brain-derived neurotrophic factor as an indication of disease state in parkinsonism and RBD

    K. Csencsits-Smith, J. Suescun, A. Gonzalez, A. Actor, M. Schiess (Houston, TX, USA)

    Objective: Evaluation of peripheral concentrations of brain-derived neurotrophic Factor (BDNF) in patients with Parkinsonian disorders and correlation with clinical measurements of disease progression to elucidate…
  • 2016 International Congress

    Clinicopathological characteristics of co-existant Parkinson’s disease and corticobasal degeneration: A case study

    K. Andruska, C. Kilbane, E. Plowey, K. Poston (Stanford, CA, USA)

    Objective: Parkinsonism is characterized by bradykinesia, rigidity, rest tremor, and postural instability. The most common cause of parkinsonism is Parkinson's disease (PD) and, rarely, Parkinson-plus…
  • 2016 International Congress

    The effects of fluvoxamine maleate in a post-natal stress rat model of neurodegeneration

    E. Dalle, W. Daniels, M. Mabandla (Durban, South Africa)

    Objective: In this study, we investigated whether treatment of anxiety-like symptoms with Fluvoxamine maleate alleviates the neurotoxic effects of 6-OHDA in a Parkinsonian rat model.…
  • 2016 International Congress

    Premotor symptoms as prognostic indicators of Parkinson’s disease: A nationwide population-based and case-control study

    M.H. Chang (Taichung, Taiwan)

    Objective: To evaluate the association between the premotor symptoms and the prognosis of Parkinson's disease (PD) by utilizing Taiwan National Health Insurance Research Database. Background:…
  • 2016 International Congress

    Retinal nerve fiber layer thinning: A window into rapid eye movement sleep behavior disorders in Parkinson’s disease

    C.J. Mao, Z.J. Yang, J. Wei, J.R. Zhang, Y.P. Yang, C.F. Liu (Suzhou, People's Republic of China)

    Objective: To determine whether retinal structures are altered with the onset of rapid eye movement (REM) in Parkinson's disease (PD). Background: Rapid eye movement (REM)…
  • 2016 International Congress

    Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson’s disease. PPMI cohort

    T. Simuni, D. Weintraub, C. Caspell-Garcia, M. Walker, C.S. Coffey, S. Lasch, C. Tanner, D. Jennings, K. Kieburtz, K. Marek, On behalf of the PPMI Investigators (Chicago, IL, USA)

    Objective: To examine baseline prevalence and longitudinal change in non-motor symptoms (NMS) in a cohort of de novo (at baseline) Parkinson's disease (PD) patients compared…
  • 2016 International Congress

    The impact of a movement disorders specialist on resident knowledge, as measured by the resident in-service training examination (RITE)

    A. Killoran (Morgantown, WV, USA)

    Objective: To determine a movement disorders specialist's impact on resident education, as assessed by the Resident In-Service Training Examination (RITE) scores. Background: Neurology resident knowledge…
  • 2016 International Congress

    Characteristics of patients initiating droxidopa for the treatment of neurogenic orthostatic hypotension (nOH)

    C. Francois, K. McLeod, A. Duhig, A. Ogbonnaya, A. Quillen, J. Cannon, B. Padilla, C.A. Shibao, I. Biaggioni (Deerfield, IL, USA)

    Objective: To understand the characteristics of patients initiating droxidopa therapy for the treatment of neurogenic orthostatic hypotension (nOH). Background: nOH is defined as a fall…
  • 2016 International Congress

    Survival and risk of mortality of synucleinopathies: A 15 years population-based study (1991 – 2005)

    R. Savica, J. Bower, C. Hagen, A.J. Eric, M.M. Mielke (Rochester, MN, USA)

    Objective: To investigate the survival and mortality of synucleinopathies 15 years of study. Background: Limited data are available to estimate the mortality and the causes…
  • « Previous Page
  • 1
  • …
  • 399
  • 400
  • 401
  • 402
  • 403
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • #28970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley